Regorafenib D3 (BAY 73-4506 D3) is the tri-deuterated form of Regorafenib (Stivarga), which is a multi-kinase inhibitor of VEGFR1, VEGFR2, VEGFR3, PDGFRβ, Kit, RET and Raf-1. It has bee approved by FDA for the treatment of liver cancer.

纯度：≥98%

CAS：1255386-16-3